• Citer

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

par Francois, Violaine ;Ottaviani, Sabrina;Renkvist, Nicolina;Stockis, Julie;Schuler, Gerold;Thielemans, Kris M.;Colau, Didier;Marchand, Marie ;Boon, Thierry;Lucas, Sophie;van der Bruggen, P
Référence Cancer research, 69, 10, page (4335-4345)
Publication Publié, 2009-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
Auteur:	Francois, Violaine; Ottaviani, Sabrina; Renkvist, Nicolina; Stockis, Julie; Schuler, Gerold; Thielemans, Kris M.; Colau, Didier; Marchand, Marie; Boon, Thierry; Lucas, Sophie; van der Bruggen, P
Informations sur la publication:	Cancer research, 69, 10, page (4335-4345)
Statut de publication:	Publié, 2009-05
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antigens, Neoplasm -- genetics -- immunology
	CD4-Positive T-Lymphocytes -- immunology
	Cancer Vaccines -- therapeutic use
	Cell Line, Tumor
	Clone Cells -- immunology
	Flow Cytometry
	Forkhead Transcription Factors -- genetics
	Humans
	Interleukin-2 -- pharmacology
	Interleukin-4 -- pharmacology
	Interleukin-7 -- pharmacology
	Lymphocyte Activation -- drug effects
	Melanoma -- immunology
	Neoplasm Proteins -- genetics -- immunology
	Peptide Fragments -- chemistry -- immunology
	T-Lymphocytes -- immunology
	T-Lymphocytes, Regulatory -- immunology
	Vaccines, Subunit -- therapeutic use
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0008-5472
	info:doi/10.1158/0008-5472.CAN-08-3726
	info:pii/0008-5472.CAN-08-3726
	info:scp/66249115337
	info:pmid/19435913